{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:12:20Z","timestamp":1773007940153,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015397","name":"Department of Science and Technology of Inner Mongolia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T07:13:13Z","timestamp":1596957193000},"page":"6553-6561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep"],"prefix":"10.1016","volume":"38","author":[{"given":"Zhigang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.002_b0005","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1111\/j.1742-4658.2011.08140.x","article-title":"Molecular basis of toxicity of Clostridium perfringens epsilon toxin","volume":"278","author":"Bokori-Brown","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2020.08.002_b0010","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1111\/j.1742-4658.2011.08145.x","article-title":"Epsilon toxin: a fascinating pore-forming toxin","volume":"278","author":"Popoff","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2020.08.002_b0015","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.addr.2005.01.017","article-title":"Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin","volume":"57","author":"Mantis","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2020.08.002_b0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0006-291X(77)90506-X","article-title":"Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin","volume":"78","author":"Bhown","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2020.08.002_b0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1348-0421.1997.tb01888.x","article-title":"Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides","volume":"41","author":"Minami","year":"1997","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.08.002_b0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/CMR.9.2.216","article-title":"Clostridial enteric diseases of domestic animals","volume":"9","author":"Songer","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.08.002_b0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/104063870802000301","article-title":"Diagnosis of Clostridium perfringens intestinal infections in sheep and goats","volume":"20","author":"Uzal","year":"2008","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2020.08.002_b0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.anaerobe.2014.08.016","article-title":"Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known","volume":"30","author":"Alves","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.vaccine.2020.08.002_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-0101(91)90105-Z","article-title":"Distribution of labeled Clostridium perfringens epsilon toxin in mice","volume":"29","author":"Nagahama","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2020.08.002_b0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1369\/jhc.4A6254.2004","article-title":"Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo","volume":"52","author":"Soler-Jover","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.vaccine.2020.08.002_b0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.toxicon.2007.04.025","article-title":"Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells","volume":"50","author":"Soler-Jover","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2020.08.002_b0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1751-0813.2003.tb11474.x","article-title":"Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review","volume":"81","author":"Finnie","year":"2003","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2020.08.002_b0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/104063870401600506","article-title":"The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep","volume":"16","author":"Uzal","year":"2004","journal-title":"J Vet Diagn Invest"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2020.08.002_b0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1099\/00221287-144-2-333","article-title":"Production of a non-toxic site-directed mutant of Clostridium perfringens epsilon-toxin which induces protective immunity in mice","volume":"144","author":"Oyston","year":"1998","journal-title":"Microbiology"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2020.08.002_b0075","doi-asserted-by":"crossref","first-page":"D44","DOI":"10.1016\/j.vaccine.2009.07.047","article-title":"Clostridium perfringens vaccines","volume":"27","author":"Titball","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.002_b0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/vr.143.17.472","article-title":"Variability of serum antibody responses of goat kids to a commercial Clostridium perfringens epsilon toxoid vaccine","volume":"143","author":"Uzal","year":"1998","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.08.002_b0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2460\/javma.1994.204.03.415","article-title":"Inflammatory response to clostridial vaccines in feedlot cattle","volume":"204","author":"Stokka","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2020.08.002_b0090","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.4161\/hv.25649","article-title":"A low-toxic site-directed mutant of Clostridium perfringens epsilon-toxin as a potential candidate vaccine against enterotoxemia","volume":"9","author":"Li","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.08.002_b0095","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.vaccine.2014.03.079","article-title":"Clostridium perfringens epsilon toxin mutant Y30A\u2013Y196A as a recombinant vaccine candidate against enterotoxemia","volume":"32","author":"Bokori-Brown","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.002_b0100","doi-asserted-by":"crossref","first-page":"24162","DOI":"10.1038\/srep24162","article-title":"Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.08.002_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-019-0128-2","article-title":"Clostridium perfringens epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein","volume":"4","author":"Morcrette","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2020.08.002_b0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nsmb804","article-title":"Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin","volume":"11","author":"Cole","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2020.08.002_b0115","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1021\/bi300690a","article-title":"Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1","volume":"51","author":"Ivie","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2020.08.002_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxicon.2015.04.006","article-title":"Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin","volume":"100","author":"Yao","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2020.08.002_b0125","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1080\/21645515.2017.1303022","article-title":"F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability","volume":"13","author":"Kang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.08.002_b0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12275-015-4523-8","article-title":"Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells","volume":"53","author":"Jiang","year":"2015","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.002_b0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1348-0421.12198","article-title":"Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids","volume":"58","author":"Jiang","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.08.002_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102417","article-title":"Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens","volume":"9","author":"Dorca-Arevalo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.08.002_b0145","first-page":"429","article-title":"Enterotoxemi of sheep. I. Effects of Clostridium perfringens type D toxin on the brains of sheep and mice","volume":"22","author":"Griner","year":"1961","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.002_b0150","first-page":"443","article-title":"Enterotoxemia of sheep. II. Distribution of I-131 radioiodinated serum albumin in brains of Clostridium perfringens type D intoxicated lambs","volume":"22","author":"Griner","year":"1961","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2020.08.002_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008014","article-title":"Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL","volume":"15","author":"Linden","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.08.002_b0160","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1074\/jbc.M011527200","article-title":"Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane","volume":"276","author":"Miyata","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.08.002_b0165","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1128\/IAI.66.6.2501-2508.1998","article-title":"Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system","volume":"66","author":"Miyamoto","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.08.002_b0170","first-page":"231","article-title":"Toxin-induced vasogenic cerebral oedema in a rat model","volume":"76","author":"Ghabriel","year":"2000","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.vaccine.2020.08.002_b0175","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1128\/IAI.00238-13","article-title":"Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice","volume":"81","author":"Garcia","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.08.002_b0180","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2527\/1997.7592328x","article-title":"Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs","volume":"75","author":"de la Rosa","year":"1997","journal-title":"J Anim Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:07Z","timestamp":1759402027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20310227"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}